FDA Enforcement Class II Ongoing

RadiForce RX360, model 0FTD2346 - Product Usage: is a color LCD monitor indicated for use in displaying radiological images for review, analysis, and diagnosis by trained medical practitioners. The display is not intended for mammography.

Recall: Z-2294-2020 · Reported June 17, 2020

Enforcement

Recall Number
Z-2294-2020
Event ID
85299
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Eizo Corporation
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Other
Report Date
June 17, 2020
Initiation Date
July 30, 2019
Classification Date
June 8, 2020
Address
Eizo ( Kabu ), N/A, Hakusan, N/A, N/A, Japan

Description

RadiForce RX360, model 0FTD2346 - Product Usage: is a color LCD monitor indicated for use in displaying radiological images for review, analysis, and diagnosis by trained medical practitioners. The display is not intended for mammography.

Reason

Under certain conditions, a marble pattern infrequently appears on the monitor.

Code Info

RadiForce RX360, 1.0001 or earlier, UDI 04995047053279, 04995047053293.

Distribution

Worldwide distribution - US Nationwide distribution including in the states of Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois, Indiana, Kansas, Louisiana, Maine, Massachusetts, Michigan, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Dakota, Tennessee, Texas, Virginia, Washington, and Wisconsin. Distribution was also made to Puerto Rico. There was no government/military consignees. The countries of Canada, Australia, Austria, Belgium, Brazil, China, Czech Republic, Egypt, France, Germany Greece, Hong Kong, India, Israel, Italy, Japan, Korea, Lebanon, Netherlands, Pakistan, Poland, Russia, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Arab Emirates, and United Kingdom.

Quantity

1,466 monitors dist. to the U.S.